Testing of New Drugs Approved From 2015 Through 2021 Under the US Pediatric Research Equity Act
This study uses public US Food and Drug Administration lists to identify new drugs approved from 2015 through 2021 to examine recent estimates of compliance with and timing of pediatric testing requirements after passage of the Pediatric Research Equity Act.
Authors
- Thomas J. Hwang (ORCID: https://orcid.org/0000-0003-0717-1497)
- Ian T. T. Liu
- Aaron Seth Kesselheim (ORCID: https://orcid.org/0000-0002-8867-2666)
Institutions
- Brigham and Women's Hospital (US)
- University of Illinois Chicago (US)
Publication Details
- Journal
- JAMA
- Published
- 2024-10-07
- DOI
- https://doi.org/10.1001/jama.2024.18338
- Citations
- 5
- Primary Topic
- Pharmaceutical studies and practices
- Type
- article
- Field-Weighted Citation Impact
- 5.55